The test-negative design for estimating influenza vaccine effectiveness-Reference-Cited by-同舟云学术

The test-negative design for estimating influenza vaccine effectiveness

Published:2013-04 Issue:17 Volume:31 Page:2165-2168
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jackson Michael L.,Nelson Jennifer C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference18 articles.

1. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep 2008Apr;57(15):393-8.

2. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season;Belongia;J Infect Dis,2009

3. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons;Eisenberg;Pediatrics,2008

4. Evidence of bias in estimates of influenza vaccine effectiveness in seniors;Jackson;Int J Epidemiol,2006

5. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors;Jackson;Int J Epidemiol,2006

Cited by 426 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness;Scientific Reports;2024-09-13

2. Effectiveness of EV-A71 Vaccine and Its Impact on the Incidence of Hand, Foot and Mouth Disease: A Systematic Review;Vaccines;2024-09-08

3. Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study;2024-08-28

4. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

5. Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection;2024-08-05